Dr Mercer has significant medical and commercial experience, most recently as Managing Director of Mercy Tissue Engineering, a successful tissue engineering company with commercial operations in Melbourne and Singapore. He brings considerable international expertise to Tissue Therapies following a successful career with multinational companies, including six years with Smith & Nephew as General Manager, Smith & Nephew Surgical, and seven years previously as a health industry specialist with IBM.

In addition to Dr Mercer's extensive commercial experience in healthcare and biotechnology, he is a Registered Medical Practitioner (Australia and USA) and a former Surgical Registrar.

Dr Mercer provides an ideal mix of skills and commercial relationships to refine and implement the Company's strategy in commercialising biomedical technologies for wound healing and tissue and cell culture. His commercial achievements with large international companies and smaller innovative biotechnology companies provide a portfolio of skills in new product development and sales and marketing that are a major asset for the Company in achieving its commercial objectives for the VitroGroŽ platform via licensing, distribution and sales.

Among his commercial achievements, Dr Mercer managed the commercialisation of the first Therapeutic Goods Administration (TGA) approved Australian human cell biotechnology laboratory, including securing the licensing of living cell implants for human use, and managing rapid growth in sales and profit derived from the facility.

Dr Mercer also successfully grew Smith & Nephew Surgical in terms of sales per employee, profit per employee and market share during his career with the company.